Status:

RECRUITING

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery

Lead Sponsor:

Universitaire Ziekenhuizen KU Leuven

Collaborating Sponsors:

Laboratoires Thea

Conditions:

Age-related Cataract

Eligibility:

All Genders

60+ years

Phase:

PHASE4

Brief Summary

To compare treatment with preservative-free dexamethasone 0.1% (Monofree Dexamethason) and diclofenac 0.1% (Dicloabak) eye drops versus preserved dexamethasone 0.1% (Maxidex) and diclofenac 0.1% (Volt...

Detailed Description

Cataract surgery is a standardized procedure yielding excellent visual outcomes in most patients. According to Daien et al., the incidence of cataract surgery in 2012 in France was 11/1000 person-year...

Eligibility Criteria

Inclusion

  • Patients diagnosed with age-related cataract
  • Age 60 years or above

Exclusion

  • Unwilling to sign informed consent
  • Pseudoexfoliation syndrome
  • Functionally monocular patient
  • Any use of eye drops during at least 3 months before surgery with the exception of artificial tears
  • Pre-existing dry eye disease according to the criteria's of the TFOS DEXS II report
  • Previous ocular surgery, laser treatment or uveitis, with the exception of retinal laser treatment (more than 6 months ago) and iridotomy (more than 6 months ago)
  • Active conjunctivitis
  • Wearing of contact lens
  • Presence of any macular diseases possibly impacting visual acuity
  • Presence of any ocular diseases leading to difficulty to have a correct eye examination
  • Known or suspected allergy to any of the ingredients on the study medications
  • Presence of uncontrolled systemic disease

Key Trial Info

Start Date :

October 30 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04050644

Start Date

October 30 2018

End Date

December 1 2024

Last Update

July 1 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Universitaire Ziekenhuizen Leuven

Leuven, Vlaams-Brabant, Belgium, 3000

2

AZ Delta

Roeselare, West-Vlaanderen, Belgium, 8800

Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery | DecenTrialz